---
title: "Artemis Medicare Services Ltd (ARTEMISMED) — Share Price, Financials & Analysis"
symbol: "ARTEMISMED"
company: "Artemis Medicare Services Ltd"
canonical: "https://tapetide.com/stocks/ARTEMISMED"
isin: "INE025R01021"
nse_symbol: "ARTEMISMED"
bse_code: "542919"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 5408.53
generated_at: "2026-09-13T18:25:20.042Z"
---

# Artemis Medicare Services Ltd (ARTEMISMED)

Canonical page: https://tapetide.com/stocks/ARTEMISMED

## Company

- **NSE Symbol:** ARTEMISMED
- **BSE Code:** 542919
- **ISIN:** INE025R01021
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2020-01-23
- **CEO:** Dr. Devlina Chakravarty DMRD, DNB, M.D., Radiology
- **Employees:** 2077
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** artemishospitals.com

## About

Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1][2]

## Latest Price

- **Price:** ₹344.9
- **Change:** -3.65 (-1.05%)
- **Open:** ₹348.55
- **Day High:** ₹351.8
- **Day Low:** ₹339.7
- **Previous Close:** ₹348.55
- **Volume:** 347172
- **As Of:** 2026-09-11T10:22:21+00:00

## Key Fundamentals

Observed at 2026-09-11T04:52:35.852924Z.

- **Market Cap:** ₹5408.53 Cr
- **Classification:** Microcap
- **P/E (reported):** 48.4
- **P/E (TTM):** 46.55
- **EPS (TTM):** ₹7.41
- **EPS (reported):** ₹4.07
- **Book Value:** ₹54.69
- **Price to Book:** 6.38
- **Dividend Yield:** 0.13%
- **ROE:** 11.03%
- **ROCE:** 13.7%
- **Debt to Equity:** 0.28
- **Revenue (yearly):** ₹1111.1 Cr
- **Net Income:** ₹103.7 Cr
- **EBITDA:** ₹218 Cr
- **52-Week High:** ₹362
- **52-Week Low:** ₹203.35
- **RSI (14):** 68.08

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 35.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 35.13 | 9% |
| growth | 46.21 | 9% |
| momentum | 72.16 | 12% |
| ownership | 42.72 | 24% |
| quality | 46.49 | 22% |
| valuation | 41.34 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 75.6% CAGR over last 5 years

### Weaknesses

- Stock is trading at 5.82 times its book value
- Company has a low return on equity of 12.1% over last 3 years.
- Promoter holding has decreased over last 3 years: -9.64%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -15.25% | 21.22% | 121.65% |
| ebitda margin growth | 4.04% | 2.99% | 24.1% | 53.64% |
| net income growth | 3.63% | 26.16% | 40% | 76% |
| revenue growth | 1.99% | 14.56% | 14% | 21% |
| roce | 5.3% | 12.02% | 8.04% | 11.45% |
| roe | 3.83% | 13.24% | 10.53% | 26.93% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 217 | 210 | 217 | 217 | 235 | 227 | 235 | 250 | 270 | 267 | 274 | 282 |
| Expenses | 184 | 179 | 181 | 181 | 193 | 190 | 199 | 209 | 220 | 223 | 224 | 227 |
| Operating Profit | 33 | 32 | 36 | 36 | 42 | 37 | 36 | 41 | 50 | 44 | 50 | 55 |
| OPM % | 15 | 15 | 17 | 16 | 18 | 16 | 15 | 16 | 19 | 16 | 18 | 20 |
| Other Income | 2 | 2 | 2 | 4 | 8 | 9 | 12 | 7 | 8 | 4 | 8 | 5 |
| Interest | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 6 |
| Depreciation | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 12 |
| Profit before tax | 19 | 16 | 19 | 22 | 31 | 27 | 29 | 30 | 40 | 30 | 39 | 42 |
| Tax % | 27 | 29 | 28 | 24 | 27 | 23 | 20 | 29 | 25 | 24 | 25 | 26 |
| Net Profit | 14 | 12 | 14 | 17 | 23 | 21 | 23 | 21 | 30 | 23 | 30 | 31 |
| EPS in Rs | 1.01 | 0.85 | 1.02 | 1.24 | 1.64 | 1.51 | 1.69 | 1.54 | 2.16 | 1.42 | 1.87 | 1.96 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 503 | 547 | 563 | 402 | 545 | 714 | 845 | 913 | 1060 | 1093 |
| Expenses | 442 | 480 | 501 | 367 | 477 | 620 | 717 | 763 | 875 | 893 |
| Operating Profit | 60 | 66 | 62 | 35 | 68 | 94 | 128 | 150 | 185 | 200 |
| OPM % | 12 | 12 | 11 | 9 | 12 | 13 | 15 | 16 | 17 | 18 |
| Other Income | 3 | 2 | 4 | 7 | 3 | 7 | 7 | 33 | 27 | 25 |
| Interest | 9 | 11 | 13 | 12 | 11 | 19 | 30 | 30 | 27 | 26 |
| Depreciation | 18 | 20 | 22 | 21 | 21 | 29 | 38 | 43 | 46 | 48 |
| Profit before tax | 35 | 37 | 32 | 9 | 39 | 53 | 68 | 109 | 139 | 151 |
| Tax % | 24 | 44 | 36 | 20 | 16 | 25 | 28 | 24 | 25 | — |
| Net Profit | 27 | 21 | 20 | 7 | 33 | 40 | 49 | 83 | 103 | 113 |
| EPS in Rs | 1.27 | 0.98 | 1.54 | 0.54 | 2.46 | 2.96 | 3.62 | 6.07 | 6.53 | 7.41 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 15 | 12 | 7 | 7 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 21 | 21 | 0 | 13 | 13 | 13 | 13 | 14 | 14 | 16 |
| Reserves | 183 | 210 | 280 | 301 | 308 | 348 | 393 | 438 | 828 | 923 |
| Borrowings | 94 | 91 | 114 | 108 | 137 | 190 | 268 | 305 | 280 | 260 |
| Other Liabilities | 124 | 130 | 160 | 159 | 130 | 145 | 207 | 191 | 221 | 225 |
| Total Liabilities | 422 | 452 | 555 | 581 | 589 | 697 | 882 | 948 | 1343 | 1424 |
| Fixed Assets | 283 | 309 | 381 | 387 | 372 | 476 | 584 | 699 | 729 | 790 |
| CWIP | 27 | 43 | 49 | 56 | 81 | 64 | 95 | 33 | 40 | 33 |
| Investments | 0 | 0 | 0 | 2 | 4 | 6 | 12 | 15 | 15 | 15 |
| Other Assets | 112 | 100 | 124 | 137 | 132 | 152 | 192 | 200 | 559 | 585 |
| Total Assets | 422 | 452 | 555 | 581 | 589 | 697 | 882 | 948 | 1343 | 1424 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 58 | 72 | 41 | 56 | 27 | 61 | 129 | 108 | 150 | 129 |
| Cash from Investing Activity | -74 | -67 | -50 | -22 | -34 | -106 | -153 | -90 | -396 | -96 |
| Cash from Financing Activity | 19 | -10 | 14 | -33 | 12 | 44 | 30 | -26 | 274 | -41 |
| Net Cash Flow | 3 | -4 | 5 | 2 | 6 | -2 | 7 | -8 | 28 | -8 |
| Free Cash Flow | -17 | 11 | -17 | 37 | 2 | -45 | -5 | 36 | 57 | 25 |
| CFO/OP | 112 | 121 | 76 | 97 | 71 | 114 | 140 | 95 | 109 | 81 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 48 | 40 | 52 | 50 | 48 | 47 | 43 | 36 | 37 | 38 |
| Inventory Days | 19 | — | — | — | — | — | — | — | — | — |
| Days Payable | 187 | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | -120 | 40 | 52 | 50 | 48 | 47 | 43 | 36 | 37 | 38 |
| Working Capital Days | -44 | -53 | -51 | -36 | -36 | -25 | -45 | -29 | -31 | -19 |
| ROCE % | 16 | 15 | 14 | 11 | 4 | 10 | 11 | 14 | 15 | 15 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 68.03% | 68.03% | 68.03% | 67.51% | 67.17% | 67.17% | 67.17% | 66.53% | 66.53% | 58.39% | 58.39% | 58.39% |
| FIIs | 0.09% | 0% | 0.1% | 0.16% | 0.22% | 0.64% | 0.31% | 0.24% | 0.37% | 12.47% | 12.19% | 12.29% |
| DIIs | 1.52% | 1.2% | 2.61% | 3.45% | 3.6% | 4.5% | 5.04% | 4.76% | 4.27% | 2.91% | 2.89% | 2.4% |
| Government | 7.18% | 7.18% | 7.18% | 7.12% | 7.09% | 7.09% | 7.09% | 7.02% | 7.02% | 6.16% | 6.16% | 6.16% |
| Public | 15.53% | 15.2% | 14.74% | 14.23% | 13.89% | 12.76% | 12.86% | 12.93% | 13.44% | 12.12% | 12.36% | 12.79% |
| Others | 7.65% | 8.39% | 7.34% | 7.53% | 8.03% | 7.84% | 7.53% | 8.52% | 8.37% | 7.96% | 8.01% | 7.97% |
| No. of Shareholders | 20529 | 22375 | 19993 | 19795 | 26054 | 27003 | 28397 | 31614 | 33559 | 31602 | 32044 | 36335 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 6 / 0

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 335.21 | Buy |
| EMA (10) | 338.08 | Buy |
| SMA (20) | 327.61 | Buy |
| EMA (20) | 329.18 | Buy |
| SMA (50) | 304.7 | Buy |
| EMA (50) | 309.64 | Buy |
| SMA (100) | 283.98 | Buy |
| EMA (100) | 290.55 | Buy |
| SMA (200) | 265.45 | Buy |
| EMA (200) | 274.61 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 64.83 | Neutral |
| MACD (12,26,9) | 11.47 | Buy |
| Stochastic (14,3,3) | 77.49 | Neutral |
| ADX (14) | 41.34 | Buy |
| Williams %R (14) | -35.66 | Neutral |
| ATR (14) | 12.19 | High Volatility |
| ROC (12) | 6.62 | Buy |
| Stoch RSI (14) | 47.86 | Neutral |
| UO (7,14,28) | 55.08 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 4 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 4 analyst ratings, observed at 2026-09-11T04:52:35.828445+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abb1e9b6-666b-4064-8e98-37c2d659b79b.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1ab46e0-e48e-4fa3-adc7-4b413d776d78.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0dc8352-8010-4a33-af6b-4f41a4b48e72.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1b4a8de-4ee1-4141-bf85-1285eba12c5e.pdf) |
| 2026-08-03 | [Board Meeting Outcome for Board Meeting Held On August 3 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=111c53aa-c0e1-4e36-8ce4-c8b9bbdd46ed.pdf) |
| 2026-08-03 | [Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d93f0c24-8554-4ad2-b668-9e1cb50213e9.pdf) |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38bd5dd0-71d2-4915-a5ff-5889c49b216f.pdf) |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a0d680f-19da-439d-8c18-afaa1e910c61.pdf) |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd919a36-af96-48cd-8a44-ae3137c05b65.pdf) |
| 2026-07-31 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19c96ff2-25aa-47e4-a5f4-44ebacb1ae6e.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4ea785e-4dde-433b-8552-b94a22bec872.pdf) |
| 2026-05-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff80b458-e136-4482-8406-921fd6ceb910.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa20321b-c9c2-4ba8-a247-cdeb11bb49db.pdf) |
| 2025-11-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5579cbf9-f4bd-40d8-a407-8fefbaf8436d.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7957156f-5ff2-43c8-9969-ec8200146f30.pdf) |
| 2026-05-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc3cbc1d-f481-430c-ba52-c927a9fc3357.pdf) |
| 2026-02-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19db0cdb-304f-43d6-9ced-00a7dcf38fbc.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8e30281-e194-4ea3-807b-9de377b2eec6.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-03 | [Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c794da-c0e6-4441-8cae-5364903292fb.pdf) |
| 2026-05-08 | [Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=019d1bdf-2ee2-49a5-a333-6e8be8de463f.pdf) |
| 2026-02-02 | [Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter/ Nine Months Period Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c5afa25-021a-45ec-8f64-489df0c00864.pdf) |
| 2025-11-11 | [Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter/ Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3654be6f-148a-4704-9345-a4ca6ffcc6fb.pdf) |
| 2025-08-05 | [Unaudited Financial Result (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb758fd6-fc6a-4f5f-aac2-7776ed1a9dee.pdf) |
| 2025-05-12 | [Audited Financial Result (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=238ba363-0ce9-4c81-9df8-8b4e7187a2bc.pdf) |
| 2025-02-05 | [Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter/ Nine Months Period Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2e57450-d2ec-43ac-8e44-f6588d4945d6.pdf) |
| 2024-11-14 | [Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter/ Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a3f54bf-4bfd-4f5a-8fbc-33e8d237dc89.pdf) |
| 2024-08-08 | [Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14df1152-ac96-4372-b31c-c14deee38755.pdf) |
| 2024-05-10 | [Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dac707f9-6588-4f03-8d08-d6a4e86c9888.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1c949b3-ec3b-4167-b6f1-4f5add5f5513.pdf) |
| 2026-05-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f88c9669-639f-4a6c-a71b-64305574cb4d.pdf) |
| 2026-02-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2252aada-e052-4198-9f8e-d501a67f5cce.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2670e2a0-c5fd-459e-a9f7-73787d41e71e.pdf) |
| 2025-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83bdbbb7-655e-40cd-a9e6-b0067e7dfbad.pdf) |
| 2025-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10595938-9f53-4ef2-b820-dc80e11b6759.pdf) |
| 2025-02-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49bbdd5c-8203-4fe0-a6d2-5a46cc3df839.pdf) |
| 2024-11-15 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4213642c-c96b-4368-a341-614362be9155.pdf) |
| 2024-08-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e73eed0d-9953-4550-af1f-37d747b50a0d.pdf) |
| 2024-05-15 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c30df5aa-80e8-429b-95c7-30ba2d9b747c.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Transcript of Earnings Conference Call - Q3 and 9M FY26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 9 Feb - Transcript of Earnings Conference Call - Q3 and 9M FY26](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fa20321b-c9c2-4ba8-a247-cdeb11bb49db.pdf) |
| 8h - Board approved FY26 audited results, 45% dividend, director appointments, auditor reappointment, and 18-month extension of preferential issue funds. | [Announcement under Regulation 30 (LODR)-Change in Directorate 8h - Board approved FY26 audited results, 45% dividend, director appointments, auditor reappointment, and 18-month extension of preferential issue funds.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/68eb8c03-13ea-489a-80de-8351501143a0.pdf) |
| 8 May - CARE report for quarter ended March 31, 2026 found no deviation in ₹330 crore preferential issue utilization. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 8 May - CARE report for quarter ended March 31, 2026 found no deviation in ₹330 crore preferential issue utilization.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/57d68e5f-50eb-43b5-b320-74c5a51bdfc9.pdf) |
| 8 May - Board approved amended fair disclosure code on May 8, 2026. | [Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information 8 May - Board approved amended fair disclosure code on May 8, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4247b43b-dc9f-4a1f-b59b-45858463b186.pdf) |
| 6 Apr - Filed Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Filed Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aaa4463a-4d3c-4d75-b38a-97a351e503ac.pdf) |
| 3 Feb - Audio recording of Q3 and 9M FY26 earnings conference call available (Feb 3, 2026) on company website. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 3 Feb - Audio recording of Q3 and 9M FY26 earnings conference call available (Feb 3, 2026) on company website.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/19db0cdb-304f-43d6-9ced-00a7dcf38fbc.pdf) |
| 2d - Q4/FY26 audited results approved; Re.0.45 final dividend, new independent directors, auditor reappointment, fund-use extension. | [Announcement under Regulation 30 (LODR)-Dividend Updates 2d - Q4/FY26 audited results approved; Re.0.45 final dividend, new independent directors, auditor reappointment, fund-use extension.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b7e4519b-a1ec-46a7-8522-8b7a040fb5ce.pdf) |
| 2d - Q4 and FY26 earnings conference call scheduled for May 11, 2026 at 11:00 AM IST. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2d - Q4 and FY26 earnings conference call scheduled for May 11, 2026 at 11:00 AM IST.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/35d807c3-b51a-4460-b123-1d05711b4174.pdf) |
| 2d - Board meets May 8, 2026 to approve FY26 audited results and consider dividend. | [Board Meeting Intimation for Consideration Of Audited Financial Results And Recommendation Of Dividend, If Any. 2d - Board meets May 8, 2026 to approve FY26 audited results and consider dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/cd0506c0-3eac-44b3-a3eb-59ea15fc9a76.pdf) |
| 29 Apr - Artemis Medicare confirms it is not a large corporate; outstanding borrowing was Rs. 225.70 crore as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Artemis Medicare confirms it is not a large corporate; outstanding borrowing was Rs. 225.70 crore as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85d8b85a-b138-4c3f-995e-3784f525e5c0.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5579cbf9-f4bd-40d8-a407-8fefbaf8436d.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4213642c-c96b-4368-a341-614362be9155.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f478692-df16-4da0-8071-fa98d41696ee.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/24bfc49f-f850-47a7-9639-e175aa8341d7.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff80b458-e136-4482-8406-921fd6ceb910.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ff80b458-e136-4482-8406-921fd6ceb910.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f88c9669-639f-4a6c-a71b-64305574cb4d.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f88c9669-639f-4a6c-a71b-64305574cb4d.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/10595938-9f53-4ef2-b820-dc80e11b6759.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c30df5aa-80e8-429b-95c7-30ba2d9b747c.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28647_TANKUP_2024_2025_A_18700185_05092025191106.pdf) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c7536bdd-b190-430f-a289-2e8a4b246db3.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a8edcae-0956-433a-bef6-1c969b3e2183.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ac534d2-ee28-435c-ae09-85ee57158a4a.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/55571f10-e73d-4883-9c6c-045c5a4f6a7e.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/542919/73226542919.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/542919/68607542919.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/542919/65271542919.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:25:20.042Z.